The global endoscopy devices market was valued at USD 61.1 billion in 2024 and is projected to reach USD 88.55 billion by 2034, growing at a CAGR of 3.82% between 2025 and 2034. This growth is driven by the rising number of surgeries, increasing prevalence of chronic disorders, and rapid technological advancements like AI-powered diagnostics and capsule endoscopy. North America currently holds the largest market share, while Asia-Pacific is expected to witness the fastest growth due to favorable manufacturing policies and expanding healthcare infrastructure. Key players include Boston Scientific, Olympus, Medtronic, and Stryker Corporation.
Download the free sample and get the full report for complete insights and forecasts on the endoscopy devices market @ https://www.towardshealthcare.com/download-sample/5425
Adoption of AI & ML in Endoscopy Devices
Enhances diagnostic accuracy and precision.
Offers real-time feedback, aiding early cancer detection.
Rise of Capsule Endoscopy & PillBot
Minimally invasive alternatives like capsule endoscopy and PillBot are gaining popularity.
PillBot clinical trials expected to finish by 2025; commercial launch projected in 2026.
Growth in Disposable and Single-Use Endoscopes
Reduces risk of cross-contamination and is supported by sustainability initiatives.
Ambu CEO advocates single-use models for patient safety and eco-friendliness.
Use of 4K and HD Visualization Systems
Enhanced resolution enables better diagnostics and surgical precision.
Integrated with cloud storage and molecular probes for improved care.
Government Initiatives to Boost Procedures
Ontario to add 60,000 publicly funded GI procedures.
UAE and Saudi Arabia report a significant rise in endoscopic procedures.
Market Valued at USD 61.1 Billion in 2024
The global endoscopy devices market is already large and continues to expand due to rising healthcare needs.
Expected to Reach USD 88.55 Billion by 2034
The market is set to grow steadily at a CAGR of 3.82%, fueled by technological innovation and surgical demand.
Endoscopes Dominate Product Segments
Wide availability of rigid, flexible, disposable, and capsule endoscopes makes them the most used tool in procedures.
Visualization Systems Gaining Traction
Advanced 4K HD systems and AI-enabled imaging are improving diagnostic accuracy and pushing growth in this segment.
Outpatient Facilities Lead End-Use in 2024
Minimally invasive procedures and faster recovery are driving endoscopy usage in outpatient settings.
Hospitals to See Lucrative Growth
Hospitals offer infrastructure, skilled professionals, and reimbursement support for complex endoscopic procedures.
North America Leads Due to Chronic Diseases
High prevalence of chronic illnesses and strong presence of top companies drive the region’s market share.
Asia-Pacific is Fastest Growing
Favorable manufacturing policies and healthcare expansion in India, China, and Southeast Asia boost regional growth.
Increasing Number of Surgeries
Over 313 million surgeries performed annually worldwide.
Endoscopy is essential for both diagnostics and treatment.
Technological Innovations
Developments in imaging (4K, 3D), robotics, AI integration.
Miniature devices enable better access and diagnostics.
Rise in Chronic Disorders
6 in 10 Americans have at least one chronic condition.
Geriatric populations need frequent diagnostic and surgical interventions.
High Cost of Devices
Average device cost in the U.S. ~USD 3,600.
High cost limits adoption in low-to-middle-income countries.
Innovation in Visualization & Robotics
3D imaging, robotic-assisted endoscopy, and capsule devices.
Use of molecular probes and cloud-integrated systems rising.
Government Support & Healthcare Funding
“Make in India” and “Made in China” initiatives support local manufacturing.
Incentives and subsidies increasing in regions like Asia-Pacific and Europe.
High prevalence of chronic diseases.
Technological maturity and presence of key players like Boston Scientific and Stryker.
Government support for local manufacturing.
High volume of surgeries and expanding healthcare infrastructure.
India and China see increased adoption of minimally invasive techniques.
Technological focus (HD, AI, robotic systems).
Favorable reimbursement policies and aging population.
Endoscopes (Dominant)
Flexible, rigid, capsule, and robot-assisted devices.
Around 200 million endoscopic procedures annually.
Visualization Systems (Growing Fast)
Use of HD monitors, light sources, camera heads.
Integrated with cloud systems and molecular detection.
Outpatient Facilities (Leading in 2024)
Preferred for minor surgeries and fast recovery.
Capsule endoscopy increases outpatient preference.
Hospitals (Emerging Growth Area)
Higher investment capacity for advanced devices.
Skilled professionals and reimbursement support.
Activ Surgical
Aesculap, Inc.
Auris Health
Boston Scientific Corporation
Conmed Corporation
C.R. Bard, Inc.
Fujifilm Holdings
Hologic
Karl Storz
Medtronic plc
Olympus Corporation
Pentax Medical
Smith & Nephew
Stryker Corporation
What is the current size and growth forecast of the endoscopy devices market?
Answer: The global endoscopy devices market is valued at USD 61.1 billion in 2024 and is projected to reach USD 88.55 billion by 2034, growing at a CAGR of 3.82% between 2025–2034.
Which product type leads the endoscopy devices market?
Answer: Endoscopes are the leading product category, driven by the wide range of flexible, rigid, and disposable options, and rising number of endoscopic procedures globally (~200 million annually).
How is AI impacting the endoscopy devices market?
Answer: AI enables real-time image analysis, cancer detection, and decision-making, improving precision and reducing the need for invasive biopsies. However, its implementation is still in early stages.
Which region is projected to grow the fastest in this market?
Answer: Asia-Pacific is projected to be the fastest-growing region due to increasing surgeries, local manufacturing policies (e.g., “Make in India”), and expanding healthcare infrastructure.
What are the biggest challenges faced by the endoscopy devices market?
Answer: High costs of acquisition, maintenance, and logistics, especially in developing countries, limit adoption. The average cost of a device in the U.S. is around USD 3,600.
Check Out Below
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5425
Access our exclusive, data-rich dashboard dedicated to the medical device industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
The global breast pump market is witnessing significant growth, valued at USD 3.23 billion in 2024 and expected to reach… Read More
The global endoscopy devices market was valued at USD 61.1 billion in 2024 and is projected to grow to USD… Read More
The global peptide synthesis market is valued at USD 774.06 million in 2025 and is projected to reach USD 2,277.59… Read More
The global cell culture market was valued at USD 22.95 billion in 2025 and is projected to reach USD 60.38… Read More
The global over the counter (OTC) drugs market was valued at USD 133.53 billion in 2024, and is projected to… Read More
The global breast pump market is valued at USD 3.23 billion in 2024 and is projected to reach USD 7.58… Read More